Rohrer Aesthetics Unveils New Clinical Study Highlighting PIX:E as the Future of Regenerative Aesthetics

HOMEWOOD, Ala., July 1, 2025 /PRNewswire/ -- Rohrer Aesthetics, a leader in energy-based aesthetic technology, is proud to announce the release of a new clinical study evaluating its innovation, PIX:E. The study, recently published by NewBeauty, spotlights the groundbreaking potential of this in-office treatment protocol – not only to rejuvenate skin, but to help prevent the visible signs of aging before they begin. By merging multiple collagen-induction technologies into one powerful platform, PIX:E is setting a bold new standard in regenerative and preventative aesthetics.

Board-certified plastic surgeon Dr. Alan Durkin led the clinical trial, which demonstrated overwhelmingly positive results. PIX:E combines the industry's only FDA-cleared 4MHz radiofrequency microneedling system with both fractional and full-field Er:YAG laser resurfacing, allowing for deeper collagen stimulation and comprehensive skin rejuvenation in a single session.

In the 20-patient study, 91% of participants reported improvements in skin tone and texture, with universal tolerability across all skin types, including those with sensitive and deeper skin tones.

"What sets PIX:E apart is its ability to seamlessly combine two gold-standard collagen-induction technologies – radiofrequency microneedling and Er:YAG laser resurfacing – into a single, efficient treatment protocol," said Dr. Durkin. "This is not only more streamlined for practices – it's a game-changer for patients. We're now able to proactively support the skin's regenerative processes, rather than just reacting to visible signs of aging. PIX:E is the future of aesthetic medicine."

Unlike traditional treatments that address aging once it appears, PIX:E is designed to intervene earlier – helping to prevent and delay the visible signs of aging by promoting the natural production of Type I collagen, the structural support behind youthful, healthy skin. This proactive approach helps maintain skin quality over time and offers a foundation for long-term aesthetic preservation.

With its advanced dual-modality design, PIX:E is redefining the standard of care for a wide range of concerns, including skin laxity, uneven tone and texture, enlarged pores, sun damage, acne scars, stretch marks, and hypertrophic scars. By addressing both surface-level and deeper dermal layers in one protocol, PIX:E offers providers a comprehensive, high-efficacy solution that replaces the need for multiple devices or sessions – while also supporting long-term skin health and aging prevention.

"We created PIX:E to simplify and elevate the way practices approach skin rejuvenation," said Liz Smith, Chief Marketing Officer at Rohrer Aesthetics. "What's most compelling, however, is the impact this has for patients – it represents a shift toward truly proactive care, allowing individuals to address the aging process before visible signs appear. With PIX:E, we're giving people a powerful way to stay ahead of the aging process and maintain healthy, youthful skin with fewer treatments and faster results. It's precision, performance, and prevention – all in one."

As regenerative aesthetics becomes an increasingly vital part of modern aesthetic care, Rohrer Aesthetics remains committed to equipping providers with clinically validated, results-driven technologies that put patient safety and satisfaction first – while empowering them to offer preventative solutions that preserve youthful skin and slow the visible aging process.

"At Rohrer Aesthetics, our mission has always been to equip providers with the tools they need to deliver exceptional results," said NJ Wazaney, CEO of Rohrer Aesthetics. "With the launch of PIX:E and the publication of this clinical study, we're reaffirming our commitment to advancing technologies that not only elevate patient outcomes, but also support the long-term success of our customers. We're continuing to invest in smart, effective solutions that meet the evolving demands of modern aesthetic care."

About Rohrer Aesthetics
Rohrer Aesthetics is one of the fastest-growing aesthetic device companies in the industry, offering 11 FDA-cleared systems that address nearly every non-invasive aesthetic need. Founded in 2014 by Mark Rohrer, the company is built on three core pillars: gold-standard technology, service excellence, and ongoing clinical education. With over 5,000 devices across the U.S., Rohrer continues to expand its footprint – driven by a Clinical Education Division that supports providers well beyond the initial sale. More than half of Rohrer customers go on to purchase additional systems as their practices grow. Rohrer Aesthetics, Inc. is a Blue Ocean Aesthetics Holdings, LLC portfolio company.

For more information about Rohrer Aesthetics, please visit our website at www.rohreraesthetics.com.

SOURCE Rohrer Aesthetics